TNFR1 loss in the antigen-retaining tumor model alters inflammatory responsiveness and CAR-T-cell functional fitness

Resistance to CAR-T-cell therapy remains a major challenge in solid tumors, where target antigen expression may be retained despite cytotoxic T-cell attack. Resistance of tumor cells to cytokine killing mediated by T-cell-secreted tumor necrosis factor (TNF) and interferon-γ (IFN-γ) may contribute to this phenotype. We investigated this possibility using a CD19 antigen-retaining tumor-cell model with differential TNFR1 status, co-cultured in vitro with CAR-T cells. CRISPR/Cas9-mediated ablation of TNFR1 in tumor cells attenuated cytokine-induced apoptotic responses. At the molecular level, TNFR1-knockout cells exhibited reduced NF-κB activation, attenuated ICAM1 induction, and diminished caspase-3/7 activity compared with WT control cells. To assess the consequences of CAR-T-cell exposure to these resistant tumor cells, CAR-T cells were analysed following both short-term and serial long-term exposure to TNFR1-knockout target cells. Although short-term assays showed no reduction in CAR-T-cell/tumor-cell conjugate formation, serial exposure to surviving TNFR1-deficient tumor cells was associated with reduced CAR-T-cell cytotoxicity upon rechallenge. These CAR-T cells also displayed lower cytokine output and altered transcriptional states. Targeted single-cell profiling identified a CXCL13-associated cycling CAR-T-cell state during tumor-cell co-culture. A transcriptional signature derived from this CAR-T state was also detectable, in an exploratory analysis, in an independently clustered repeated CD3/CD28-stimulation dataset and in publicly available immune checkpoint blockade cohorts. Taken together, our findings support the hypothesis that prolonged exposure to antigen-positive tumor cells that survive inflammatory cytokine-mediated killing may reduce subsequent CAR-T-cell functional fitness and cytotoxic potential.

Authors

Institutions

Publication Details

Journal
Cell Death and Disease
Published
2026-11-21
DOI
https://doi.org/10.1038/s41419-026-09406-5
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

TNFR1 loss in the antigen-retaining tumor model alters inflammatory responsiveness and CAR-T-cell functional fitness

Bayansulu Ilyassova, Ksenia Levchuk, Nickolai A. Barlev, Alexey V. Pindyurin et al.
Cell Death and Disease
CAR-T cell therapy research
article

TNFR1 loss in the antigen-retaining tumor model alters inflammatory responsiveness and CAR-T-cell functional fitness

Bayansulu Ilyassova, Ksenia Levchuk, Nickolai A. Barlev, Alexey V. Pindyurin, Shynggys Tursymbek, Sergey Silonov, Evgeniya Omelina, Alexey Petukhov
article en

Abstract

Resistance to CAR-T-cell therapy remains a major challenge in solid tumors, where target antigen expression may be retained despite cytotoxic T-cell attack. Resistance of tumor cells to cytokine killing mediated by T-cell-secreted tumor necrosis factor (TNF) and interferon-γ (IFN-γ) may contribute to this phenotype. We investigated this possibility using a CD19 antigen-retaining tumor-cell model with differential TNFR1 status, co-cultured in vitro with CAR-T cells. CRISPR/Cas9-mediated ablation of TNFR1 in tumor cells attenuated cytokine-induced apoptotic responses. At the molecular level, TNFR1-knockout cells exhibited reduced NF-κB activation, attenuated ICAM1 induction, and diminished caspase-3/7 activity compared with WT control cells. To assess the consequences of CAR-T-cell exposure to these resistant tumor cells, CAR-T cells were analysed following both short-term and serial long-term exposure to TNFR1-knockout target cells. Although short-term assays showed no reduction in CAR-T-cell/tumor-cell conjugate formation, serial exposure to surviving TNFR1-deficient tumor cells was associated with reduced CAR-T-cell cytotoxicity upon rechallenge. These CAR-T cells also displayed lower cytokine output and altered transcriptional states. Targeted single-cell profiling identified a CXCL13-associated cycling CAR-T-cell state during tumor-cell co-culture. A transcriptional signature derived from this CAR-T state was also detectable, in an exploratory analysis, in an independently clustered repeated CD3/CD28-stimulation dataset and in publicly available immune checkpoint blockade cohorts. Taken together, our findings support the hypothesis that prolonged exposure to antigen-positive tumor cells that survive inflammatory cytokine-mediated killing may reduce subsequent CAR-T-cell functional fitness and cytotoxic potential.

Cell Death and Disease
Russian Academy of Sciences (RU), Institute of Cytology (RU), Institute of Molecular and Cell Biology (RU), Astana Medical University (KZ), National Research Center for Maternal and Child Health (KZ), Nazarbayev University (KZ)
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon